Tonix Pharmaceuticals Hol... (TNXP)
7.43
-0.43 (-5.47%)
At close: Mar 03, 2025, 3:59 PM
7.56
1.68%
After-hours: Mar 03, 2025, 04:45 PM EST
Tonix Pharmaceuticals Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| PE Ratio | -5.89 | -12.18 | -141.24 | -122.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -45.37K | -1.48M | -850.13K | -1.24M |
| PEG Ratio | 0.09 | 0.20 | 2.61 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.34 | 34.77K | -18.46K | n/a |
| PS Ratio | 88.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 6.51 | 6.87 | 59.60 | 72.85 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -64.16K | -4.62M | 2.18M | 611.53K |
| P/FCF Ratio | -6.25 | -9.73 | -117.57 | -111.76 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -59.63K | -1.46M | -941.55K | -1.11M |
| P/OCF Ratio | -6.73 | -14.51 | -172.51 | -131.47 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -59.69K | -1.46M | -941.55K | -1.11M |
| OCF/S Ratio | -13.13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.09 | 0.00 | 0.00 | 0.01 | 0.04 | n/a | n/a | n/a | n/a | n/a | 0.04 | n/a | -0.85 | n/a | n/a | n/a |
| Quick Ratio | 1.78 | 7.64 | 9.06 | 9.74 | 2.91 | 9.81 | 12.44 | 12.83 | 6.97 | 11.54 | 3.90 | 1.77 | 0.16 | 0.45 | 13.19 | 15.30 |
| Current Ratio | 2.53 | 7.19 | 8.71 | 8.96 | 2.72 | 9.81 | 12.44 | 12.83 | 6.97 | 11.54 | 3.90 | 1.77 | 0.16 | 0.45 | 13.19 | 15.30 |
| Asset Turnover | 0.05 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.72K | -4.13 | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -1.11 | -0.56 | -0.42 | -0.6 | -3.3 | -1.24 | -0.86 | -1.53 | -1.19 | -0.77 | -1.67 | -0.01 | 1.41 | 3.12 | -2.56 | -0.49 |
| Return on Assets (ROA) | -0.76 | -0.52 | -0.38 | -0.53 | -2.14 | -1.12 | -0.79 | -1.41 | -1.02 | -0.7 | -1.25 | -0.00 | -8.16 | -3.83 | -2.37 | -0.46 |
| Return on Capital (ROIC) | -0.87 | -0.54 | -0.42 | -0.57 | -3.06 | -1.11 | -0.86 | -1.53 | -1.19 | -0.76 | -1.67 | -6.81 | 6.76 | 3.12 | -2.56 | -0.49 |
| Dividend Yield | n/a | 0.00 | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | -0.06 | n/a | -0.01 | -0.08 | -0.11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 38.97% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -1.5K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -1.5K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -1.52K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -1.41K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -1.47K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |